Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03044431
What this trial is testing

Autologous Stem Cell Treatment for Chronic Lung Disease Study

Who this might be right for
COPDInterstitial Lung Disease
Lung Institute 207
Testing effectiveness (Phase 2)Looking for participantsNCT05746039
What this trial is testing

Feasibility of Semaglutide in Advanced Lung Disease

Who this might be right for
ObesityInterstitial Lung DiseaseChronic Obstructive Pulmonary Disease+2 more
University of Pennsylvania 8
Not applicableStudy completedNCT03944928
What this trial is testing

ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 30
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Testing effectiveness (Phase 2)Looking for participantsNCT04925375
What this trial is testing

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseCommon Variable Immunodeficiency
Children's Hospital Medical Center, Cincinnati 38
Large-scale testing (Phase 3)Study completedNCT00578565
What this trial is testing

Rituximab in Rheumatoid Arthritis Lung Disease

Who this might be right for
Rheumatoid ArthritisInterstitial Pneumonia
Eric Matteson 10
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Not applicableUnknownNCT01499745
What this trial is testing

Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Rabin Medical Center 40
Not applicableUnknownNCT03798028
What this trial is testing

The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Xijing Hospital 250
Not applicableUnknownNCT02827734
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Pulmonary Healthy ControlsInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Universitätsmedizin Mannheim 50
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Not applicableUnknownNCT02509364
What this trial is testing

Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

Who this might be right for
Interstitial Lung Diseases
Shanghai Pulmonary Hospital, Shanghai, China 300
Not applicableActive Not RecruitingNCT04680832
What this trial is testing

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 600
Large-scale testing (Phase 3)Looking for participantsNCT04943211
What this trial is testing

Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging

Who this might be right for
Histiocytosis
Anna Raciborska 150
Early research (Phase 1)Study completedNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 45
Not applicableEnded earlyNCT02821039
What this trial is testing

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study

Who this might be right for
Idiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Turkish Thoracic Society 1,678
Not applicableUnknownNCT03801135
What this trial is testing

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Who this might be right for
Humoral RejectionGuillain-Barre SyndromeMiller Fisher Syndrome+3 more
University Medical Centre Ljubljana 20
Testing effectiveness (Phase 2)Study completedNCT00468208
What this trial is testing

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

Who this might be right for
Wegener's Granulomatosis
University of Pennsylvania 20
Testing effectiveness (Phase 2)Looking for participantsNCT06582745
What this trial is testing

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

Who this might be right for
Langerhans Cell Histiocytosis
Cook Children's Health Care System 75
Next Page